Complexities in estimating the true risk of hereditary leiomyomatosis and renal cell carcinoma and the development of kidney cancer

Cancer. 2020 Aug 15;126(16):3617-3619. doi: 10.1002/cncr.32915. Epub 2020 May 15.
No abstract available

Keywords: HLRCC; cancer genetics; hereditary; hereditary leiomyomatosis and renal cell cancer; kidney cancer.

Publication types

  • Editorial
  • Research Support, N.I.H., Intramural

MeSH terms

  • Carcinoma, Renal Cell / complications
  • Carcinoma, Renal Cell / genetics*
  • Carcinoma, Renal Cell / pathology
  • Fumarate Hydratase / genetics*
  • Genetic Predisposition to Disease
  • Humans
  • Kidney Neoplasms / etiology
  • Kidney Neoplasms / genetics*
  • Kidney Neoplasms / pathology
  • Leiomyomatosis / complications
  • Leiomyomatosis / genetics*
  • Leiomyomatosis / pathology
  • Neoplastic Syndromes, Hereditary / complications
  • Neoplastic Syndromes, Hereditary / genetics*
  • Neoplastic Syndromes, Hereditary / pathology
  • Skin Neoplasms / complications
  • Skin Neoplasms / genetics*
  • Skin Neoplasms / pathology
  • Uterine Neoplasms / complications
  • Uterine Neoplasms / genetics*
  • Uterine Neoplasms / pathology

Substances

  • Fumarate Hydratase

Supplementary concepts

  • Hereditary leiomyomatosis and renal cell cancer